Cargando…
Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc(+) Monocytes in Rectal Cancer
Neoadjuvant radiochemotherapy (nRCT) can significantly influence the tumor immune architecture that plays a pivotal role in regulating tumor growth. Whereas, various studies have investigated the effect of nRCT on tumor-infiltrating T cells, little is known about its impact on the frequency and acti...
Autores principales: | Wagner, Felix, Hölig, Ulrike, Wilczkowski, Friederike, Plesca, Ioana, Sommer, Ulrich, Wehner, Rebekka, Kießler, Maximilian, Jarosch, Armin, Flecke, Katharina, Arsova, Maia, Tunger, Antje, Bogner, Andreas, Reißfelder, Christoph, Weitz, Jürgen, Schäkel, Knut, Troost, Esther G. C., Krause, Mechthild, Folprecht, Gunnar, Bornhäuser, Martin, Bachmann, Michael P., Aust, Daniela, Baretton, Gustavo, Schmitz, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450462/ https://www.ncbi.nlm.nih.gov/pubmed/30984181 http://dx.doi.org/10.3389/fimmu.2019.00602 |
Ejemplares similares
-
Current Concepts on 6-sulfo LacNAc Expressing Monocytes (slanMo)
por: Ahmad, Fareed, et al.
Publicado: (2019) -
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis
por: Thomas, Katja, et al.
Publicado: (2014) -
Phenotype, Function, and Mobilization of 6-Sulfo LacNAc-Expressing Monocytes in Atopic Dermatitis
por: Baran, Wojciech, et al.
Publicado: (2018) -
6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes
por: Hofer, Thomas P., et al.
Publicado: (2019) -
A Novel Modular Antigen Delivery System for Immuno Targeting of Human 6-sulfo LacNAc-Positive Blood Dendritic Cells (SlanDCs)
por: Bippes, Claudia C., et al.
Publicado: (2011)